Ibopamine

DB13316ExperimentalSmall molecule

Ibopamine is a sympathomimetic, indicated in the induction of mydriasis and treatment of pos-surgical ocular hypotonia. A medication used to treat low pressure in the eye after surgery or to dilate the pupils.

Formula / weight: C₁₇H₂₅NO₄ · 307.3847 g/mol (avg)

Resolves to

Compound

UNII8ZCA2I2L11CAS66195-31-1ChEMBLCHEMBL307739ChEBI135306

Clinical / RWD

RxNorm51253ATCC01CA16ATCS01FB03

Structure

InChIKeyWDKXLLJDNUBYCY-UHFFFAOYSA-NSMILESCNCCC1=CC(OC(=O)C(C)C)=C(OC(=O)C(C)C)C=C1

What you can answer from here — as of June 02, 2021

1,247Drug interactionsStructured to mechanism, not free text

5Structured indicationsCondition, population, route and combination as fields, not prose

3ContraindicationsEach with its own population and attribute set

11Marketed productsAcross 1 country and 3 labellers

2ATC codesIncluding every combination product, plus 28 drug categories

1+ReferenceStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Ibopamine, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account